EFTA01175291Dataset 9
2008-07-302p580w
…8 agree upon those securities which constitute Family Investments, if any. As used herein, "Family Investments" shall mean limited 9 partnership interests in ZAFFARONI Family Partnership, investments in privately held of publicly-traded stock issued by companies in 10 which the Trustors played key roles as founders or otherwise, 11 including, but not limited to, Oxonica PLC Ordinary shares (private placement) and Xenoport, Inc., and securities issued by Digital 12 Arts/Gallery Systems, Alivita, Inc., and Technogen Managers, LLC." 13 …
https://www.justice.gov/epstein/files/DataSet%209/EFTA01175291.pdf
EFTA01840267Dataset 10
2008-07-302p592w
…8 agree upon those securities which constitute Family Investments, if any. As used herein, "Family Investments" shall mean limited 9 partnership interests in ZAFFARONI Family Partnership, investments in privately held of publicly-traded stock issued by companies in 10 which the Trustors played key roles as founders or otherwise. 1i including, but not limited to, Oxonica PLC Ordinary shares (private placement) and Xenoport, Inc., and securities issued by Digital 12 Arts/Galleay Systems, Alivita, Inc., and Tecimegen Managers, LW." 13 …
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01840267.pdf
EFTA02697300Dataset 11
2008-07-302p594w
…8 agree upon those securities which constitute Family Investments, if any. As used herein, "Family Investments" shall mean limited 9 partnership interests in ZAFFARONI Family Partnership, investments in privately held of publicly-traded stock issued by companies in 10 which the Trustors played key roles as founders or otherwise. including, but not limited to, Oxonica PLC Ordinary shares (private 1i placement) and Xenoport, Inc., and securities issued by Digital 12 Arts/Cralleay Systems, Alivita, Inc., and Technogen Managers, LW." 13 …
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02697300.pdf
EFTA00598607Dataset 9
2014-07-2313p8,093w
…Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa. Inc.. Synageva Biopharma Corp, Theravance Inc, Ultragenyx Pharmaceutical Inc, Versartis. Inc., Vertex Pharmaceuticals, XenoPort Inc. Within the last 12 months. Morgan Stanley has received compensation for products and services other than investment banking services from Amgen Inc.. Auxilium Pharmaceuticals. Biogen idec Inc.. Celgene Corp, Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals. Within the last 12 months. Morgan Stanley has provided or is providing Investment banking services to. or has an investment banking client relationship with, the…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00598607.pdf
EFTA01199408Dataset 9
2014-07-2313p8,089w
…Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc., Relypsa. Inc.. Synageva Biopharma Corp, Theravance Inc, Ultragenyx Pharmaceutical Inc, Versartis. Inc., Vertex Pharmaceuticals, XenoPort Inc. Within the last 12 months. Morgan Stanley has received compensation for products and services other than investment banking services from Amgen Inc.. Auxilium Pharmaceuticals. Biogen idec Inc.. Celgene Corp, Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals. Within the last 12 months. Morgan Stanley has provided or is providing Investment banking services to. or has an investment banking client relationship with, the…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01199408.pdf
EFTA00598622Dataset 9
14p8,563w
…Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc., Relypsa, Inc.. Synageva Biopharma Corp, Theravance Inc, Ultragenyx Pharmaceutical Inc, Versartis, Inc., Vertex Pharmaceuticals. XenoPort Inc. Within the last 12 months. Morgan Stanley has received compensation for products and services other than investment banking services from Amgen Inc.. Auxilium Pharmaceuticals. Biogen Mee Inc., Celgene Corp. Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals. Within the last 12 months. Morgan Stanley has provided or is providing investment banking services to. or has an investment banking client relationship with, the…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00598622.pdf
EFTA01199422Dataset 9
14p8,572w
…Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc., Relypsa, Inc.. Synageva Biopharma Corp, Theravance Inc, Uftragenyx Pharmaceutical Inc, Versartis. Inc., Vertex Pharmaceuticals. XenoPort Inc. Within the last 12 months. Morgan Stanley has received compensation for products and services other than investment banking services from Amgen Inc., Auxilium Pharmaceuticals. Biogen Mee Inc., Celgene Corp. Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals. Within the last 12 months. Morgan Stanley has provided or is providing investment banking services to. or has an investment banking client relationship with, the…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01199422.pdf